Elderly do benefit from induction chemotherapy: High dose mitoxantrone based ( “5+1”) induction chemotherapy regimen in newly diagnosed acute myeloid leukemia
In conclusion, HDM based chemotherapy regimen produces high CR rates, is well tolerated and more patients can undergo curative post‐remission therapy including stem cell transplant.This article is protected by copyright. All rights reserved.
Source: American Journal of Hematology - Category: Hematology Authors: Neeraj Saini,
Jan Cerny,
Vanessa Furtado,
Angela Desmond,
Zheng Zhou,
Glen Raffel,
Imran Puthawala,
Jayde Bednarik,
Lindsey Shanahan,
Patricia Miron,
Bruce Woda,
Muthalagu Ramanathan,
Rajneesh Nath Tags: RESEARCH ARTICLE Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Chemotherapy | Hematology | Leukemia | Stem Cell Therapy | Stem Cells | Transplants